TN2012000267A1 - Nouveaux derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents
Nouveaux derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennentInfo
- Publication number
- TN2012000267A1 TN2012000267A1 TNP2012000267A TN2012000267A TN2012000267A1 TN 2012000267 A1 TN2012000267 A1 TN 2012000267A1 TN P2012000267 A TNP2012000267 A TN P2012000267A TN 2012000267 A TN2012000267 A TN 2012000267A TN 2012000267 A1 TN2012000267 A1 TN 2012000267A1
- Authority
- TN
- Tunisia
- Prior art keywords
- hex
- derivatives
- preparing
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- -1 HEX-2-YL Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0905953A FR2953521B1 (fr) | 2009-12-09 | 2009-12-09 | Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2010/000823 WO2011070253A1 (fr) | 2009-12-09 | 2010-12-08 | Derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2012000267A1 true TN2012000267A1 (fr) | 2013-12-12 |
Family
ID=42711699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2012000267A TN2012000267A1 (fr) | 2009-12-09 | 2012-05-28 | Nouveaux derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Country Status (32)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3043799A1 (en) * | 2013-09-09 | 2016-07-20 | Sanofi | An h3 receptor antagonist combined with a cholinesterase inhibitor for use in the treatment of alzheimer's disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0507680D0 (en) * | 2005-04-15 | 2005-05-25 | Glaxo Group Ltd | Compounds |
| CA2630270A1 (en) * | 2005-11-30 | 2007-06-07 | F. Hoffmann-La Roche Ag | 5-substituted indole-2-carboxamide derivatives |
-
2009
- 2009-12-09 FR FR0905953A patent/FR2953521B1/fr not_active Expired - Fee Related
-
2010
- 2010-12-01 UY UY0001033072A patent/UY33072A/es unknown
- 2010-12-03 TW TW099142190A patent/TW201200499A/zh unknown
- 2010-12-06 AR ARP100104484A patent/AR079265A1/es not_active Application Discontinuation
- 2010-12-07 SA SA110320011A patent/SA110320011B1/ar unknown
- 2010-12-08 AU AU2010329762A patent/AU2010329762B2/en not_active Ceased
- 2010-12-08 MA MA34932A patent/MA33882B1/fr unknown
- 2010-12-08 GE GEAP201012774A patent/GEP20156227B/en unknown
- 2010-12-08 JP JP2012542591A patent/JP2013513589A/ja not_active Ceased
- 2010-12-08 PE PE2012000722A patent/PE20121475A1/es not_active Application Discontinuation
- 2010-12-08 IN IN4966DEN2012 patent/IN2012DN04966A/en unknown
- 2010-12-08 AP AP2012006352A patent/AP2012006352A0/xx unknown
- 2010-12-08 CA CA2782469A patent/CA2782469C/fr not_active Expired - Fee Related
- 2010-12-08 BR BR112012013666A patent/BR112012013666A2/pt not_active IP Right Cessation
- 2010-12-08 CN CN2010800559947A patent/CN102652127A/zh active Pending
- 2010-12-08 EP EP10799080A patent/EP2509947A1/fr not_active Withdrawn
- 2010-12-08 MX MX2012006578A patent/MX2012006578A/es active IP Right Grant
- 2010-12-08 KR KR1020127017843A patent/KR20120102763A/ko not_active Ceased
- 2010-12-08 UA UAA201208178A patent/UA102950C2/ru unknown
- 2010-12-08 EA EA201200849A patent/EA201200849A1/ru unknown
- 2010-12-08 US US13/514,796 patent/US20120283245A1/en not_active Abandoned
- 2010-12-08 WO PCT/FR2010/000823 patent/WO2011070253A1/fr not_active Ceased
- 2010-12-08 SG SG2012038931A patent/SG181082A1/en unknown
- 2010-12-08 PH PH1/2012/501053A patent/PH12012501053A1/en unknown
-
2012
- 2012-05-28 TN TNP2012000267A patent/TN2012000267A1/fr unknown
- 2012-05-29 CR CR20120286A patent/CR20120286A/es unknown
- 2012-05-30 ZA ZA2012/03943A patent/ZA201203943B/en unknown
- 2012-06-05 EC ECSP12011950 patent/ECSP12011950A/es unknown
- 2012-06-06 CO CO12095636A patent/CO6541535A2/es unknown
- 2012-06-06 CL CL2012001479A patent/CL2012001479A1/es unknown
- 2012-06-07 NI NI201200099A patent/NI201200099A/es unknown
- 2012-06-07 CU CU20120091A patent/CU20120091A7/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA45223A (fr) | Nouveaux dérivés de pipéridinyle subsitués par (hétéro)aryle, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| FR3037958B1 (fr) | Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA30883B1 (fr) | Nouveaux derives de 1,1 - dioxyde de 1.4 - benzothiepine substitues par des radicaux benzyle, leur procede de preparation, les produits pharmaceutiques comprenant ces composes et leur utilisation | |
| MA34359B1 (fr) | Dérivés de carbamate d'hexafluoroisopropyle, leur préparation et leur application thérapeutique | |
| FR3037957B1 (fr) | Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
| MA37206B1 (fr) | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA45222B1 (fr) | Nouveaux dérivés de pipéridinyle, procédé de préparation de ceux-ci et compositions pharmaceutiques les contenant | |
| EA200602191A1 (ru) | 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения | |
| MA42232B1 (fr) | Nouveaux dérivés d'acide aminé, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| EA201000436A1 (ru) | Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью | |
| MA29653B1 (fr) | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| TN2009000307A1 (fr) | Nouveaux derives tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EA201070804A1 (ru) | (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения | |
| FR3041639B1 (fr) | NOUVEAUX DERIVES D'IMIDAZO[4,5-b]PYRIDINE, PROCEDE POUR LES PREPARER ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT | |
| MA34008B1 (fr) | Composes en tant qu'antagonistes de la bradykinine b1 | |
| TN2010000025A1 (fr) | Derives de l'indol -2-one disubstitues en 3, leur preparation et leur application en therapeutique | |
| MA29258B1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EA200702375A1 (ru) | Производные мочевины, способы их получения и применения | |
| TW200637817A (en) | 5-aminoindole derivatives | |
| ATE482955T1 (de) | Azabicyclooctan-3-onderivate und deren verwendung | |
| TN2012000166A1 (fr) | NOUVEAUX DERIVES (HETEROCYCLE-TETRAHYDRO-PYRIDINE)-(PIPERAZINYL)-1-ALCANONE ET (HETEROCYCLE-DIHYDRO-PYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE ET LEUR UTILISATION COMME INHIBITEURS DE p75 | |
| TN2010000542A1 (fr) | Nouveaux derives azabicylco[3.2.0]hept 3-yl leur procede de preparation et les compositons pharmaceutiques qui les contiennent | |
| MA29257B1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| TN2009000216A1 (fr) | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |